A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: marks (231), results (1000)

Irinotecan Ver 1.2

Description
Chemotherapy Protocol COLORECTAL CANCER Regimen IRINOTECAN Colorectal Cancer– Irinotecan Indication Second line treatment of advanced colorectal cancer WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/IrinotecanVer12.pdf

Fluorouracil-Folinic Acid-Irinotecan

Description
Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL, FOLINIC ACID (Modified de Gramont) and IRINOTECAN (FOLFIRI) Regimen • Colorectal Cancer– Fluorouracil, Folinic Acid (Modified de
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-FolinicAcid-Irinotecan.pdf

Ibrutinib-Venetoclax

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia IBRUTINIB-VENETOCLAX Regimen CLL – Ibrutinib & Venetoclax Indication • Ibrutinib plus Venetoclax is recommended as an option for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib-Venetoclax-Ver1.1.pdf

Sexual function after radical cystectomy - Information for women - patient information

Description
This factsheet explains how a radical cystectomy can affect sexual function and ways to help manage these changes.
Url
/Media/UHS-website-2019/Patientinformation/Surgery/Sexual-function-after-radical-cystectomy-Information-for-women-3743-PIL.pdf

AmB-Axicabtagene ciloleucel-Cyclophosphamide (500)-Fludarabine (30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY Large B-cell Lymphoma (LBL) AmB- AXICEL – CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Axicabtagene-ciloleucel-Cyclophosphamide-500-Fludarabine-30.pdf

AmB - Brexucel - Cyclophosphamide (500) - Fludarabine (30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY Mantle Cell lymphoma (MCL) AmB – BREXUCEL – CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) Ambulatory
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Brexucel-Cyclophosphamide-500-Fludarabine-30-Ver-1.pdf

Brexucel - Cyclophosphamide (900) - Fludarabine (25)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – BREXUCEL – CYCLOPHOSPHAMIDE (900) – FLUDARABINE (25) This regimen will only be
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Brexucel-Cyclophosphamide-900-Fludarabine-25.pdf

UHS AR 22-23-6

Description
2022/23 Incorporating the quality account University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2022/23 Presented to Parliament
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-22-23-6.pdf

Carboplatin(AUC5)Etoposide

Description
Regimen Chemotherapy Protocol BRAIN TUMOURS CARBOPLATIN (AUC5)-ETOPOSIDE • Brain – Carboplatin (AUC5)-Etoposide Indication • Third line treatment of glioblastoma multiforme • WHO Performance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/CarboplatinAUC5-Etoposide.pdf

Brexucel - Cyclophosphamide (500) - Fludarabine (30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY MCL – BREXUCEL – CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) This regimen will only be
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Brexucel-Cyclophosphamide-500-Fludarabine-30.pdf
511 to 520 of 548
Previous … 50 51 52 53 54 … Next